SCHEMBL30906343

CSCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.69

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	11/20	0.65

▸	GCGR	P47871	8/20	0.65

▸	CRHR1	P34998	1/20	0.60

▸	CRHR2	Q13324	1/20	0.60

▸	CALCR	P30988	3/20	0.59

▸	NMBR	P28336	1/20	0.59

▸	GRPR	P30550	1/20	0.59

▸	C5AR1	P21730	1/20	0.58

▸	GIPR	P48546	5/20	0.57

▸	CCKBR	P32239	2/20	0.57

▸	KEAP1	Q14145	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906544	0.95	GLP1R (0.62)	GLP1RGCGRCRHR1CRHR2CALCR
SCHEMBL30906445	0.93	GLP1R (0.63)	GLP1RGCGRCALCRCCKBR
SCHEMBL30906405	0.93	GLP1R (0.62)	GLP1RGCGRCALCRCCKBR
SCHEMBL30906528	0.89	GLP1R (0.63)	GLP1RGCGRC5AR1CCKBR
SCHEMBL30906407	0.89	GLP1R (0.58)	GLP1RGIPR
SCHEMBL30968310	0.88	GLP1R (0.68)	GLP1RGCGRCRHR1CRHR2CALCR
SCHEMBL30658317	0.88	GLP1R (0.71)	GLP1RGCGRCRHR1CRHR2CALCR
SCHEMBL30658377	0.86	GLP1R (0.73)	GLP1RGCGRCALCRC5AR1GIPR
SCHEMBL30906418	0.86	NPY1R (0.57)	GLP1RGIPR
SCHEMBL31182863	0.86	C5AR1 (0.70)	GLP1RGCGRC5AR1GIPRCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed